Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo.
Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo.
复制标题
DOI:
10.1126/sciadv.aat7314
复制
发表时间:
2018-08
期刊:
影响因子:
13.6
通讯作者:
de Graaf RA
中科院分区:
文献类型:
--
作者:
De Feyter HM;Behar KL;Corbin ZA;Fulbright RK;Brown PB;McIntyre S;Nixon TW;Rothman DL;de Graaf RA
DMI shows metabolism of acetate and glucose in the brain and liver and reveals the Warburg effect in patients with brain tumors. Currently, the only widely available metabolic imaging technique in the clinic is positron emission tomography (PET) detection of the radioactive glucose analog 2-18F-fluoro-2-deoxy-d-glucose (18FDG). However, 18FDG-PET does not inform on metabolism downstream of glucose uptake and often provides ambiguous results in organs with intrinsic high glucose uptake, such as the brain. Deuterium metabolic imaging (DMI) is a novel, noninvasive approach that combines deuterium magnetic resonance spectroscopic imaging with oral intake or intravenous infusion of nonradioactive 2H-labeled substrates to generate three-dimensional metabolic maps. DMI can reveal glucose metabolism beyond mere uptake and can be used with other 2H-labeled substrates as well. We demonstrate DMI by mapping metabolism in the brain and liver of animal models and human subjects using [6,6′-2H2]glucose or [2H3]acetate. In a rat glioma model, DMI revealed pronounced metabolic differences between normal brain and tumor tissue, with high-contrast metabolic maps depicting the Warburg effect. We observed similar metabolic patterns and image contrast in two patients with a high-grade brain tumor after oral intake of 2H-labeled glucose. Further, DMI used in rat and human livers showed [6,6′-2H2]glucose stored as labeled glycogen. DMI is a versatile, robust, and easy-to-implement technique that requires minimal modifications to existing clinical magnetic resonance imaging scanners. DMI has great potential to become a widespread method for metabolic imaging in both (pre)clinical research and the clinic.
登录
查看更多内容
影响因子:
5.3
作者:
Lebon, V;Petersen, KF;Rothman, DL
通讯作者:
Rothman, DL
影响因子:
6.3
作者:
Lu, Ming;Zhu, Xiao-Hong;Chen, Wei
通讯作者:
Chen, Wei
影响因子:
14.8
作者:
Macallan, Derek C.;Asquith, Becca;Beverley, Peter C. L.
通讯作者:
Beverley, Peter C. L.
影响因子:
3.4
作者:
AGUAYO, JB;MCLENNAN, IJ;CHENG, HM
通讯作者:
CHENG, HM
影响因子:
14.8
作者:
Busch, Robert;Neese, Richard A.;Hellerstein, Marc K.
通讯作者:
Hellerstein, Marc K.